BioDiem, Changchun BCHT deal

BioDiem granted Changchun exclusive rights to its live attenuated influenza virus (LIAV) technology for an egg-based production method for pandemic and seasonal influenza vaccines for the private market

Read the full 283 word article

How to gain access

Continue reading with a
two-week free trial.